Markets pull back from record highs U.S. stocks traded unevenly Monday as investors digested rising political pressure on the Federal Reserve, shaking confidence in the central bank’s independence. The Dow Jones Industrial Average slipped below flatline levels, while the S&P
A $1 billion bet on AI-driven medicine AI chip leader Nvidia and pharmaceutical giant Eli Lilly announced a joint $1 billion investment to build a new artificial intelligence–focused drug discovery lab in San Francisco. The lab will be funded over
A strategic AI pivot Apple has entered a multi-year partnership with Google to use its Gemini artificial intelligence models to power next-generation Siri features, marking one of the most significant shifts in Apple’s AI strategy in years. Under the agreement,
Markets react to budget signals Defense stocks surged globally after comments from Washington indicated plans to dramatically expand U.S. military spending, fueling investor optimism around long-term weapons procurement and defense infrastructure investment. In U.S. trading, Northrop Grumman and Lockheed Martin
What’s changing Nvidia is imposing unusually strict payment terms on Chinese customers seeking its H200 artificial intelligence chips, requiring full upfront payment before orders are accepted, according to people familiar with the matter. Under the policy, buyers must commit capital
What happened U.S. stocks pushed higher on Wednesday, extending a strong start to 2026 — but the session had a “foot-off-the-gas” feel underneath the headlines. The S&P 500 rose about 0.3%, while the Dow Jones Industrial Average dipped roughly 0.1%
Oil Shipments Go Beyond the First Tranche A continuing flow, not a one-time transfer Venezuela will ship sanctioned oil to the United States on an ongoing, indefinite basis, according to sources close to the White House. The U.S. president said
Musk Pushes Back on Nvidia’s CES Reveal Confidence in Tesla’s FSD lead Elon Musk said Tuesday that it would take five to six years — or longer — before Nvidia’s latest autonomous driving technology poses serious competition to Tesla’s Full
U.S. Demand Forces Meta to Hit Pause Supply can’t keep up Meta Platforms announced it is delaying the international rollout of its Ray-Ban Display AI glasses after demand in the United States far exceeded expectations. According to the company, product
A New Push Toward Oral Weight-Loss Treatments AI meets metabolic medicine Nimbus Therapeutics announced a new research and licensing agreement with Eli Lilly to develop next-generation, AI-driven oral treatments for obesity and other metabolic diseases. Under the deal: The collaboration
Markets pull back from record highs U.S. stocks traded unevenly Monday as investors digested rising
A $1 billion bet on AI-driven medicine AI chip leader Nvidia and pharmaceutical giant Eli
A strategic AI pivot Apple has entered a multi-year partnership with Google to use its
Markets react to budget signals Defense stocks surged globally after comments from Washington indicated plans
What’s changing Nvidia is imposing unusually strict payment terms on Chinese customers seeking its H200
What happened U.S. stocks pushed higher on Wednesday, extending a strong start to 2026 —
Oil Shipments Go Beyond the First Tranche A continuing flow, not a one-time transfer Venezuela
Musk Pushes Back on Nvidia’s CES Reveal Confidence in Tesla’s FSD lead Elon Musk said
U.S. Demand Forces Meta to Hit Pause Supply can’t keep up Meta Platforms announced it
A New Push Toward Oral Weight-Loss Treatments AI meets metabolic medicine Nimbus Therapeutics announced a
